Mechanisms of obesity-induced gastrointestinal neoplasia

Gastroenterology

Volumn 146, Issue 2, 2014, Pages 357-373

  Alemán, José O ^a   Eusebi, Leonardo H ^b   Ricciardiello, Luigi ^b   Patidar, Kavish ^c   Sanyal, Arun J ^c   Holt, Peter R ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Pancreatic Cancer

Indexed keywords

ADIPOCYTOKINE; INSULIN; SEX HORMONE; SOMATOMEDIN C;

ABDOMINAL OBESITY; ADIPOSE TISSUE; APOPTOSIS; BINDING KINETICS; CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ENDOTOXEMIA; ESOPHAGUS CANCER; GENETIC ASSOCIATION; HEREDITY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE CELL; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE METAPLASIA; MACROPHAGE ACTIVATION; MOLECULAR DYNAMICS; NUTRIENT UPTAKE; OBESITY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH MUCOSA; WHITE ADIPOSE TISSUE; WNT SIGNALING PATHWAY;

BARRETT'S ESOPHAGUS; BE; BMI; BODY MASS INDEX; COLORECTAL CANCER; CRC; EAC; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL CANCER; GASTRIC ADENOCARCINOMA; GASTRIC CANCER; GASTROINTESTINAL; GCA; GI; IGF; IGFBP; IGFR; IL; INSULIN RECEPTOR; INSULIN-LIKE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN; INSULIN-LIKE GROWTH FACTOR RECEPTOR; INTERLEUKIN; IR; LIPOPOLYSACCHARIDES; LPS; MAMMALIAN TARGET OF RAPAMYCIN; MAPK; MCP-1; MICROSATELLITE INSTABILITY; MITOGEN-ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOATTRACTANT PROTEIN 1; MSI; MTOR; PAC; PANCREATIC ADENOCARCINOMA; PANCREATIC CANCER; RELATIVE RISK; RR; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 2; STNFR2; TNF; TUMOR NECROSIS FACTOR;

ADENOCARCINOMA; BIOLOGICAL MARKERS; DIET; GASTROINTESTINAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INTESTINES; MICROBIOTA; OBESITY; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84892742096     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.11.051     Document Type: Review

References (235)

1. C.L. Ogden, S.Z. Yanovski, and M.D. Carroll et al. The epidemiology of obesity Gastroenterology 132 2007 2087 2102
2. K.R. Fontaine, D.T. Redden, and C. Wang et al. Years of life lost due to obesity JAMA 289 2003 187 193
3. A.G. Renehan, M. Tyson, and M. Egger et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 2008 569 578
4. K.Y. Wolin, K. Carson, and G.A. Colditz Obesity and cancer Oncologist 15 2013 556 565
5. N. Kloting, M. Fasshauer, and A. Dietrich et al. Insulin-sensitive obesity Am J Physiol Endocrinol Metab 299 2010 E506 E515
6. W. Demark-Wahnefried, E.A. Platz, and J.A. Ligibel et al. The role of obesity in cancer survival and recurrence Cancer Epidemiol Biomarkers Prev 21 2012 1244 1259
7. R.S. Yalow, and S.A. Berson Immunoassay of endogenous plasma insulin in man J Clin Invest 39 1960 1157 1175
8. E.P. Joslin, H.L. Lombard, and R.E. Burrows et al. Diabetes and cancer N Engl J Med 260 1959 486 488
9. H.M. Lakka, J.T. Salonen, and J. Tuomilehto et al. Obesity and weight gain are associated with increased incidence of hyperinsulinemia in non-diabetic men Horm Metab Res 34 2002 492 498
10. J.C. Heuson, and N. Legros Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction Cancer Res 32 1972 226 232
11. R.J. DeBerardinis, and C.B. Thompson Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148 2012 1132 1144
12. O. Warburg, F. Wind, and E. Negelein The metabolism of tumors in the body J Gen Physiol 8 1927 519 530
13. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
14. M. Jenab, E. Riboli, and R.J. Cleveland et al. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition Int J Cancer 121 2007 368 376
15. J.W. Finkelstein, J. Kream, and A. Ludan et al. Sulfation factor (somatomedin): an explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors J Clin Endocrinol Metab 35 1972 13 17
16. S.M. Orme, R.J. McNally, and R.A. Cartwright et al. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group J Clin Endocrinol Metab 83 1998 2730 2734
17. Z. Laron The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome J Clin Endocrinol Metab 84 1999 4397 4404
18. O. Shevah, and Z. Laron Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report Growth Horm IGF Res 17 2007 54 57
19. D.J. Brick, A.V. Gerweck, and E. Meenaghan et al. Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity Eur J Endocrinol 163 2010 185 191
20. F. El Yafi, R. Winkler, and P. Delvenne et al. Altered expression of type I insulin-like growth factor receptor in Crohn's disease Clin Exp Immunol 139 2005 526 533
21. J.B. van Goudoever, W. Corpeleijn, and M. Riedijk et al. The impact of enteral insulin-like growth factor 1 and nutrition on gut permeability and amino acid utilization J Nutr 138 2008 1829S 1833S
22. J.P. Peyrat, J. Bonneterre, and R. Beuscart et al. Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors Cancer Res 48 1988 6429 6433
23. E.J. Gallagher, and D. LeRoith Minireview: IGF, insulin, and cancer Endocrinology 152 2011 2546 2551
24. A.A. Butler, and D. LeRoith Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology Endocrinology 142 2001 1685 1688
25. E. Giovannucci Nutrition, insulin, insulin-like growth factors and cancer Horm Metab Res 35 2003 694 704
26. E. Giovannucci Metabolic syndrome, hyperinsulinemia, and colon cancer: a review Am J Clin Nutr 86 2007 s836 s842
27. L.S. Hart, N.G. Dolloff, and D.T. Dicker et al. Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab Cell Cycle 10 2011 2331 2338
28. M.N. Pollak, J.W. Chapman, and K.I. Pritchard et al. NCIC-CTG MA14 Trial: tamoxifen (tam) vs. tam + octreotide (oct) for adjuvant treatment of stage I or II postmenopausal breast cancer (abstr) J Clin Oncol 26 suppl 2008 532
29. P. Haluska, H.M. Shaw, and G.N. Batzel et al. Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors Clin Cancer Res 13 2007 5834 5840
30. P. Haluska, F. Worden, and D. Olmos et al. Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma Cancer Chemother Pharmacol 65 2010 765 773
31. J. Jassem, C.J. Langer, and D.D. Karp et al. Randomized, open label, phase III trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) (abstr) J Clin Oncol 28 suppl 2010 7500
32. O.A. MacDougald, and C.F. Burant The rapidly expanding family of adipokines Cell Metab 6 2007 159 161
33. R. Luo, X. Li, and R. Jiang et al. Serum concentrations of resistin and adiponectin and their relationship to insulin resistance in subjects with impaired glucose tolerance J Int Med Res 40 2012 621 630
34. Y. Zhang, R. Proenca, and M. Maffei et al. Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
35. J.N. Fain, A.K. Madan, and M.L. Hiler et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans Endocrinology 145 2004 2273 2282
36. K.L. Houseknecht, C.S. Mantzoros, and R. Kuliawat et al. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity Diabetes 45 1996 1638 1643
37. S. Margetic, C. Gazzola, and G.G. Pegg et al. Leptin: a review of its peripheral actions and interactions Int J Obes Relat Metab Disord 26 2002 1407 1433
38. C. Grunfeld, C. Zhao, and J. Fuller et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters J Clin Invest 97 1996 2152 2157
39. C. Garofalo, and E. Surmacz Leptin and cancer J Cell Physiol 207 2006 12 22
40. J.E. Drew, A.J. Farquharson, and S. Padidar et al. Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine Am J Physiol Gastrointest Liver Physiol 293 2007 G682 G691
41. M.R. Hoda, S.J. Keely, and L.S. Bertelsen et al. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells Br J Surg 94 2007 346 354
42. F. Capel, E. Klimcakova, and N. Viguerie et al. Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization Diabetes 58 2009 1558 1567
43. P.B. White, E.M. True, and K.M. Ziegler et al. Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth J Gastrointest Surg 14 2010 1888 1893 discussion 1893-1894
44. D.P. Rose, and L. Vona-Davis The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression Endocr Relat Cancer 19 2012 R225 R241
45. J.A. Sennello, R. Fayad, and A.M. Morris et al. Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin Endocrinology 146 2005 2157 2164
46. N. Ouchi, S. Kihara, and T. Funahashi et al. Obesity, adiponectin and vascular inflammatory disease Curr Opin Lipidol 14 2003 561 566
47. A. Gavrila, C.K. Peng, and J.L. Chan et al. Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns J Clin Endocrinol Metab 88 2003 2838 2843
48. H. Motoshima, X. Wu, and M.K. Sinha et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone J Clin Endocrinol Metab 87 2002 5662 5667
49. P.A. Kern, G.B. Di Gregorio, and T. Lu et al. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression Diabetes 52 2003 1779 1785
50. F. Ziemke, and C.S. Mantzoros Adiponectin in insulin resistance: lessons from translational research Am J Clin Nutr 91 2010 258S 261S
51. H. Storgaard, P. Poulsen, and C. Ling et al. Relationships of plasma adiponectin level and adiponectin receptors 1 and 2 gene expression to insulin sensitivity and glucose and fat metabolism in monozygotic and dizygotic twins J Clin Endocrinol Metab 92 2007 2835 2839
52. R. Shibata, N. Ouchi, and S. Kihara et al. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling J Biol Chem 279 2004 28670 28674
53. M. Dalamaga, I. Migdalis, and J.L. Fargnoli et al. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study Cancer Causes Control 20 2009 625 633
54. M. Ishikawa, J. Kitayama, and S. Kazama et al. Plasma adiponectin and gastric cancer Clin Cancer Res 11 2005 466 472
55. B. Wu, K. Fukuo, and K. Suzuki et al. Relationships of systemic oxidative stress to body fat distribution, adipokines and inflammatory markers in healthy middle-aged women Endocr J 56 2009 773 782
56. T. Yamauchi, J. Kamon, and Y. Minokoshi et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat Med 8 2002 1288 1295
57. M.N. Vansaun Molecular pathways: adiponectin and leptin signaling in cancer Clin Cancer Res 19 2013 1926 1932
58. T. Yokota, K. Oritani, and I. Takahashi et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 96 2000 1723 1732
59. K. Ohashi, J.L. Parker, and N. Ouchi et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype J Biol Chem 285 2010 6153 6160
60. C.A. Derby, S. Zilber, and D. Brambilla et al. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study Clin Endocrinol (Oxf) 65 2006 125 131
61. J.H. Lin, and E. Giovannucci Sex hormones and colorectal cancer: what have we learned so far? J Natl Cancer Inst 102 2010 1746 1747
62. A. Rudolph, C. Toth, and M. Hoffmeister et al. Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-beta Cancer Res 73 2013 3306 3315
63. C. Bouchard, and A. Tremblay Genetic influences on the response of body fat and fat distribution to positive and negative energy balances in human identical twins J Nutr 127 1997 943S 947S
64. R.K. Lee, D.S. Hittel, and V.Z. Nyamandi et al. Unconventional microarray design reveals the response to obesity is largely tissue specific: analysis of common and divergent responses to diet-induced obesity in insulin-sensitive tissues Appl Physiol Nutr Metab 37 2012 257 268
65. M.J. Gunter, and M.F. Leitzmann Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes J Nutr Biochem 17 2006 145 156
66. X. Yang, J.L. Deignan, and H. Qi et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks Nat Genet 41 2009 415 423
67. P. Gulati, M.K. Cheung, and R. Antrobus et al. Role for the obesity-related FTO gene in the cellular sensing of amino acids Proc Natl Acad Sci U S A 110 2013 2557 2562
68. R. Vongsuvanh, J. George, and L. Qiao et al. Visceral adiposity in gastrointestinal and hepatic carcinogenesis Cancer Lett 330 2013 1 10
69. C.R. Balistreri, C. Caruso, and G. Candore The role of adipose tissue and adipokines in obesity-related inflammatory diseases Mediators Inflamm 2010 2010 802078
70. Y. Ben-Neriah, and M. Karin Inflammation meets cancer, with NF-kappaB as the matchmaker Nat Immunol 12 2011 715 723
71. G.H. Goossens, E.E. Blaak, and R. Theunissen et al. Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans Mol Immunol 50 2012 142 149
72. A. Poullis, R. Foster, and A. Shetty et al. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk Cancer Epidemiol Biomarkers Prev 13 2004 279 284
73. S. Pendyala, L.M. Neff, and M. Suarez-Farinas et al. Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis Am J Clin Nutr 93 2011 234 242
74. C.N. Lumeng, and A.R. Saltiel Inflammatory links between obesity and metabolic disease J Clin Invest 121 2011 2111 2117
75. S. Cinti, G. Mitchell, and G. Barbatelli et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans J Lipid Res 46 2005 2347 2355
76. K.J. Strissel, Z. Stancheva, and H. Miyoshi et al. Adipocyte death, adipose tissue remodeling, and obesity complications Diabetes 56 2007 2910 2918
77. J.M. Olefsky, and C.K. Glass Macrophages, inflammation, and insulin resistance Annu Rev Physiol 72 2010 219 246
78. M. Feuerer, L. Herrero, and D. Cipolletta et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters Nat Med 15 2009 930 939
79. R. Cancello, C. Henegar, and N. Viguerie et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss Diabetes 54 2005 2277 2286
80. I. Imayama, C.M. Ulrich, and C.M. Alfano et al. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial Cancer Res 72 2012 2314 2326
81. M. Spencer, B.S. Finlin, and R. Unal et al. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance Diabetes 62 2013 1709 1717
82. N. Stefan, K. Kantartzis, and J. Machann et al. Identification and characterization of metabolically benign obesity in humans Arch Intern Med 168 2008 1609 1616
83. R. Golan, I. Shelef, and A. Rudich et al. Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes Diabetes Care 35 2012 640 647
84. S. Pendyala, J.M. Walker, and P.R. Holt A high-fat diet is associated with endotoxemia that originates from the gut Gastroenterology 142 2012 1100 1101.e2
85. F. Backhed, H. Ding, and T. Wang et al. The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci U S A 101 2004 15718 15723
86. V.K. Ridaura, J.J. Faith, and F.E. Rey et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 341 2013 1241214
87. P.J. Turnbaugh, M. Hamady, and T. Yatsunenko et al. A core gut microbiome in obese and lean twins Nature 457 2009 480 484
88. S. Ding, M.M. Chi, and B.P. Scull et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse PLoS One 5 2010 e12191
89. C.B. de La Serre, C.L. Ellis, and J. Lee et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation Am J Physiol Gastrointest Liver Physiol 299 2010 G440 G448
90. P.D. Cani, J. Amar, and M.A. Iglesias et al. Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772
91. R.E. Ley, F. Backhed, and P. Turnbaugh et al. Obesity alters gut microbial ecology Proc Natl Acad Sci U S A 102 2005 11070 11075
92. R.E. Ley, P.J. Turnbaugh, and S. Klein et al. Microbial ecology: human gut microbes associated with obesity Nature 444 2006 1022 1023
93. G. Musso, R. Gambino, and M. Cassader Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes Annu Rev Med 62 2011 361 380
94. J.P. Furet, L.C. Kong, and J. Tap et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers Diabetes 59 2010 3049 3057
95. S.H. Duncan, G.E. Lobley, and G. Holtrop et al. Human colonic microbiota associated with diet, obesity and weight loss Int J Obes (Lond) 32 2008 1720 1724
96. J.C. Arthur, E. Perez-Chanona, and M. Muhlbauer et al. Intestinal inflammation targets cancer-inducing activity of the microbiota Science 338 2012 120 123
97. A. Vrieze, E. Van Nood, and F. Holleman et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome Gastroenterology 143 2012 913 916.e7
98. E. van Nood, A. Vrieze, and M. Nieuwdorp et al. Duodenal infusion of donor feces for recurrent Clostridium difficile N Engl J Med 368 2013 407 415
99. A. Jemal, F. Bray, and M.M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
100. S.C. Larsson, and A. Wolk Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies Am J Clin Nutr 86 2007 556 565
101. T.C. Koch, K. Briviba, and B. Watzl et al. Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather than hyperinsulinemia Eur J Nutr 47 2008 161 170
102. W.R. Bruce, T.M. Wolever, and A. Giacca Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance Nutr Cancer 37 2000 19 26
103. D. Komninou, A. Ayonote, and J.P. Richie Jr. et al. Insulin resistance and its contribution to colon carcinogenesis Exp Biol Med (Maywood) 228 2003 396 405
104. A. Ouban, P. Muraca, and T. Yeatman et al. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas Hum Pathol 34 2003 803 808
105. J.I. Jones, and D.R. Clemmons Insulin-like growth factors and their binding proteins: biological actions Endocr Rev 16 1995 3 34
106. Y.S. Guo, S. Narayan, and C. Yallampalli et al. Characterization of insulinlike growth factor I receptors in human colon cancer Gastroenterology 102 1992 1101 1108
107. P. Singh, and N. Rubin Insulinlike growth factors and binding proteins in colon cancer Gastroenterology 105 1993 1218 1237
108. J.I. Fenton, N.G. Hord, and J.A. Lavigne et al. Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines Cancer Epidemiol Biomarkers Prev 14 2005 1646 1652
109. H. Takahashi, T. Takayama, and K. Hosono et al. Correlation of the plasma level of insulin-like growth factor-1 with the number of aberrant crypt foci in male individuals Mol Med Rep 2 2009 339 343
110. H. Endo, K. Hosono, and T. Uchiyama et al. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis Gut 60 2011 1363 1371
111. S. Attoub, V. Noe, and L. Pirola et al. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways FASEB J 14 2000 2329 2338
112. J.E. Drew Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin Proc Nutr Soc 71 2012 175 180
113. S. Padidar, A.J. Farquharson, and L.M. Williams et al. Leptin up-regulates pro-inflammatory cytokines in discrete cells within mouse colon J Cell Physiol 226 2011 2123 2130
114. E.J. Park, J.H. Lee, and G.Y. Yu et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Cell 140 2010 197 208
115. P. Stattin, A. Lukanova, and C. Biessy et al. Obesity and colon cancer: does leptin provide a link? Int J Cancer 109 2004 149 152
116. P. Stattin, R. Palmqvist, and S. Soderberg et al. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden Oncol Rep 10 2003 2015 2021
117. K. Tamakoshi, H. Toyoshima, and K. Wakai et al. Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan Oncology 68 2005 454 461
118. G.Y. Ho, T. Wang, and M.J. Gunter et al. Adipokines linking obesity with colorectal cancer risk in postmenopausal women Cancer Res 72 2012 3029 3037
119. K. Aleksandrova, H. Boeing, and M. Jenab et al. Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort Cancer Res 72 2012 5328 5337
120. S. Uddin, P.P. Bavi, and A.R. Hussain et al. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication Carcinogenesis 30 2009 1832 1840
121. V. Tutino, M. Notarnicola, and V. Guerra et al. Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients Anticancer Res 31 2011 3381 3383
122. M. Song, X. Zhang, and K. Wu et al. Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study Cancer Prev Res 6 2013 875 885
123. V.M. Chia, P.A. Newcomb, and J.W. Lampe et al. Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk Cancer Epidemiol Biomarkers Prev 16 2007 2697 2703
124. H.S. Moon, X. Liu, and J.M. Nagel et al. Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice Gut 62 2013 561 570
125. T. Fujisawa, H. Endo, and A. Tomimoto et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition Gut 57 2008 1531 1538
126. K. Ohashi, N. Ouchi, and Y. Matsuzawa Adiponectin and hypertension Am J Hypertens 24 2011 263 269
127. X.T. Xu, Q. Xu, and J.L. Tong et al. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma J Dig Dis 12 2011 234 244
128. K. Aleksandrova, H. Boeing, and M. Jenab et al. Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study Carcinogenesis 33 2012 1211 1218
129. Y.C. Chung, and Y.F. Chang Serum interleukin-6 levels reflect the disease status of colorectal cancer J Surg Oncol 83 2003 222 226
130. S. Kim, T.O. Keku, and C. Martin et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas Cancer Res 68 2008 323 328
131. S. Grivennikov, E. Karin, and J. Terzic et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer Cancer Cell 15 2009 103 113
132. C. Becker, M.C. Fantini, and S. Wirtz et al. IL-6 signaling promotes tumor growth in colorectal cancer Cell Cycle 4 2005 217 220
133. A.T. Chan, S. Ogino, and E.L. Giovannucci et al. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs Gastroenterology 140 2011 799 808 quiz e11
134. S. Paruchuri, O. Broom, and K. Dib et al. The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells J Biol Chem 280 2005 13538 13544
135. A.K. Sikalidis, and B. Varamini Roles of hormones and signaling molecules in describing the relationship between obesity and colon cancer Pathol Oncol Res 17 2011 785 790
136. M.E. Martinez, D. Heddens, and D.L. Earnest et al. Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa J Natl Cancer Inst 91 1999 950 953
137. A. Klaus, and W. Birchmeier Wnt signalling and its impact on development and cancer Nat Rev Cancer 8 2008 387 398
138. A.J. Levine, Z. Feng, and T.W. Mak et al. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways Genes Dev 20 2006 267 275
139. T. Morikawa, A. Kuchiba, and X. Liao et al. Tumor TP53 expression status, body mass index and prognosis in colorectal cancer Int J Cancer 131 2012 1169 1178
140. S. Ogino, K. Nosho, and K. Shima et al. p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis Cancer Epidemiol Biomarkers Prev 18 2009 2513 2521
141. S. Ogino, K. Nosho, and N. Irahara et al. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers J Clin Oncol 27 2009 4591 4598
142. T. Morikawa, A. Kuchiba, and P. Lochhead et al. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with beta-catenin (CTNNB1) status Cancer Res 73 2013 1600 1610
143. T. Morikawa, A. Kuchiba, and M. Yamauchi et al. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer JAMA 305 2011 1685 1694
144. M.C. Boutron-Ruault, P. Senesse, and S. Meance et al. Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence Nutr Cancer 39 2001 50 57
145. M.L. Slattery, J. Potter, and B. Caan et al. Energy balance and colon cancer - beyond physical activity Cancer Res 57 1997 75 80
146. D.S. Michaud, C.S. Fuchs, and S. Liu et al. Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women Cancer Epidemiol Biomarkers Prev 14 2005 138 147
147. L. Kushi, and E. Giovannucci Dietary fat and cancer Am J Med 113 suppl 9B 2002 63S 70S
148. E.D. Parker, and A.R. Folsom Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study Int J Obes Relat Metab Disord 27 2003 1447 1452
149. K. Rapp, J. Klenk, and H. Ulmer et al. Weight change and cancer risk in a cohort of more than 65,000 adults in Austria Ann Oncol 19 2008 641 648
150. A. Papathanasopoulos, and M. Camilleri Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions Gastroenterology 138 2010 65 72 e1-2
151. T.D. Adams, R.E. Gress, and S.C. Smith et al. Long-term mortality after gastric bypass surgery N Engl J Med 357 2007 753 761
152. L. Sjostrom, A. Gummesson, and C.D. Sjostrom et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial Lancet Oncol 10 2009 653 662
153. M. Derogar, M.A. Hull, and P. Kant et al. Increased risk of colorectal cancer after obesity surgery Ann Surg 258 2013 983 988
154. M.P. Ostlund, Y. Lu, and J. Lagergren Risk of obesity-related cancer after obesity surgery in a population-based cohort study Ann Surg 252 2010 972 976
155. M. Derogar, M.A. Hull, and P. Kant et al. Increased risk of colorectal cancer after obesity surgery Ann Surg 258 2013 983 988
156. J. Ferlay, H.R. Shin, and F. Bray et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
157. E.L. Bird-Lieberman, and R.C. Fitzgerald Early diagnosis of oesophageal cancer Br J Cancer 101 2009 1 6
158. A. Kubo, and D.A. Corley Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis Cancer Epidemiol Biomarkers Prev 15 2006 872 878
159. C.C. Abnet, N.D. Freedman, and A.R. Hollenbeck et al. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma Eur J Cancer 44 2008 465 471
160. M. Solaymani-Dodaran, R.F. Logan, and J. West et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux Gut 53 2004 1070 1074
161. G.W. Falk Barrett's esophagus Gastroenterology 122 2002 1569 1591
162. A. Chak, G. Falk, and W.M. Grady et al. Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction Am J Gastroenterol 104 2009 1913 1921
163. H. Hampel, N.S. Abraham, and H.B. El-Serag Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications Ann Intern Med 143 2005 199 211
164. Z.R. Edelstein, D.C. Farrow, and M.P. Bronner et al. Central adiposity and risk of Barrett's esophagus Gastroenterology 133 2007 403 411
165. D.A. Corley, A. Kubo, and T.R. Levin et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus Gastroenterology 133 2007 34 41 quiz 311
166. P. Beddy, J. Howard, and C. McMahon et al. Association of visceral adiposity with oesophageal and junctional adenocarcinomas Br J Surg 97 2010 1028 1034
167. L.A. Anderson, R.G. Watson, and S.J. Murphy et al. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study World J Gastroenterol 13 2007 1585 1594
168. P.J. de Jonge, E.W. Steyerberg, and E.J. Kuipers et al. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus Am J Gastroenterol 101 2006 1421 1429
169. T.L. Vaughan, A.R. Kristal, and P.L. Blount et al. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 11 2002 745 752
170. Z. Jin, J.P. Hamilton, and J. Yang et al. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression Cancer Epidemiol Biomarkers Prev 17 2008 111 117
171. J.R. Olliver, L.J. Hardie, and Y. Gong et al. Risk factors, DNA damage, and disease progression in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 14 2005 620 625
172. R.A. Risques, T.L. Vaughan, and X. Li et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 16 2007 2649 2655
173. A.S. Ali, S. Ali, and A. Ahmad et al. Expression of microRNAs: potential molecular link between obesity, diabetes and cancer Obes Rev 12 2011 1050 1062
174. B.S. Zhao, S.G. Liu, and T.Y. Wang et al. Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses Asian Pac J Cancer Prev 14 2013 139 143
175. E.E. Kershaw, and J.S. Flier Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 2004 2548 2556
176. R.L. Weinsier, G.R. Hunter, and B.A. Gower et al. Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss Am J Clin Nutr 74 2001 631 636
177. G.L. Vega, B. Adams-Huet, and R. Peshock et al. Influence of body fat content and distribution on variation in metabolic risk J Clin Endocrinol Metab 91 2006 4459 4466
178. J.S. Yudkin Adipose tissue, insulin action and vascular disease: inflammatory signals Int J Obes Relat Metab Disord 27 suppl 3 2003 S25 S28
179. R.C. van Kruijsdijk, E. van der Wall, and F.L. Visseren Obesity and cancer: the role of dysfunctional adipose tissue Cancer Epidemiol Biomarkers Prev 18 2009 2569 2578
180. C.L. Donohoe, S.L. Doyle, and S. McGarrigle et al. Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma Br J Surg 99 2012 387 396
181. S.L. Doyle, C.L. Donohoe, and S.P. Finn et al. IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity Am J Gastroenterol 107 2012 196 204
182. S.H. Siahpush, T.L. Vaughan, and J.N. Lampe et al. Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 16 2007 2387 2395
183. J.M. Howard, P. Beddy, and D. Ennis et al. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma Br J Surg 97 2010 1020 1027
184. A. Yildirim, M. Bilici, and K. Cayir et al. Serum adiponectin levels in patients with esophageal cancer Jpn J Clin Oncol 39 2009 92 96
185. C. Duggan, L. Onstad, and S. Hardikar et al. Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma Clin Gastroenterol Hepatol 11 2013 934 943
186. P.C. Konturek, G. Burnat, and T. Rau et al. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line Dig Dis Sci 53 2008 597 605
187. B.J. Kendall, G.A. Macdonald, and N.K. Hayward et al. Leptin and the risk of Barrett's oesophagus Gut 57 2008 448 454
188. I.L. Beales, and O.O. Ogunwobi Leptin synergistically enhances the anti-apoptotic and growth-promoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture Mol Cell Endocrinol 274 2007 60 68
189. D. Barb, C.J. Williams, and A.K. Neuwirth et al. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am J Clin Nutr 86 2007 s858 s866
190. O.O. Ogunwobi, and I.L. Beales Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and TGFα-mediated transactivation of the epidermal growth factor receptor Br J Biomed Sci 65 2008 121 127
191. P. Somasundar, D. Riggs, and B. Jackson et al. Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms Am J Surg 186 2003 575 578
192. O. Ogunwobi, G. Mutungi, and I.L. Beales Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation Endocrinology 147 2006 4505 4516
193. O.M. Thompson, S.A. Beresford, and E.A. Kirk et al. Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction Obesity (Silver Spring) 18 2010 2204 2211
194. D.G. Silberg, J. Sullivan, and E. Kang et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice Gastroenterology 122 2002 689 696
195. J.M. Gu, W.J. Xiao, and J.W. He et al. Association between VDR and ESR1 gene polymorphisms with bone and obesity phenotypes in Chinese male nuclear families Acta Pharmacol Sin 30 2009 1634 1642
196. X. Chen, G. Lou, and Z. Meng et al. TGR5: a novel target for weight maintenance and glucose metabolism Exp Diabetes Res 2011 2011 853501
197. M. Watanabe, S.M. Houten, and C. Mataki et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation Nature 439 2006 484 489
198. H. Wen, J.P. Ting, and L.A. O'Neill A role for the NLRP3 inflammasome in metabolic diseases - did Warburg miss inflammation? Nat Immunol 13 2012 352 357
199. L. Yang, X. Lu, and C.W. Nossa et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome Gastroenterology 137 2009 588 597
200. W.H. Chow, W.J. Blot, and T.L. Vaughan et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia J Natl Cancer Inst 90 1998 150 155
201. J. Lagergren, R. Bergstrom, and O. Nyren Association between body mass and adenocarcinoma of the esophagus and gastric cardia Ann Intern Med 130 1999 883 890
202. P. Yang, Y. Zhou, and B. Chen et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies Eur J Cancer 45 2009 2867 2873
203. B.P. Wijnhoven, P.D. Siersema, and W.C. Hop et al. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group Br J Surg 86 1999 529 535
204. H.B. Wang, C.J. Zhou, and S.Z. Song et al. Evaluation of Nrf2 and IGF-1 expression in benign, premalignant and malignant gastric lesions Pathol Res Pract 207 2011 169 173
205. M. Hull, and J. Lagergren Obesity and Colorectal cancer Gut 63 2014 205
206. J. Matsubara, Y. Yamada, and T.E. Nakajima et al. Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer Oncology 74 2008 76 83
207. T.E. Nakajima, Y. Yamada, and T. Hamano et al. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer J Gastroenterol 44 2009 685 690
208. M. Seker, A. Bilici, and B. Sonmez et al. The association of serum adiponectin levels with histopathological variables in gastric cancer patients Med Oncol 27 2010 1319 1323
209. J.M. Friedman Leptin and the regulation of body weigh Keio J Med 60 2010 1 9
210. R. Pai, C. Lin, and T. Tran et al. Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation Biochem Biophys Res Commun 331 2005 984 992
211. D. Shida, J. Kitayama, and K. Mori et al. Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells Cancer Res 65 2005 9159 9163
212. L.G. Capelle, A.C. de Vries, and J. Haringsma et al. Serum levels of leptin as marker for patients at high risk of gastric cancer Helicobacter 14 2009 596 604
213. X. Zhao, K. Huang, and Z. Zhu et al. Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer J Gastroenterol Hepatol 22 2007 1317 1321
214. H. Kai, Y. Kitadai, and M. Kodama et al. Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma Anticancer Res 25 2005 709 713
215. T. Kuroda, Y. Kitadai, and S. Tanaka et al. Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment Clin Cancer Res 11 2005 7629 7636
216. R. Thompson Preventing cancer: the role of food, nutrition and physical activity J Fam Health Care 20 2010 100 102
217. L. Jiao, A. Berrington de Gonzalez, and P. Hartge et al. Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts Cancer Causes Control 21 2010 1305 1314
218. D. Li, J.S. Morris, and J. Liu et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer JAMA 301 2009 2553 2562
219. P. Stattin, O. Bjor, and P. Ferrari et al. Prospective study of hyperglycemia and cancer risk Diabetes Care 30 2007 561 567
220. P. Pisani Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies Arch Physiol Biochem 114 2008 63 70
221. R.Z. Stolzenberg-Solomon, B.I. Graubard, and S. Chari et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers JAMA 294 2005 2872 2878
222. D.S. Michaud, B. Wolpin, and E. Giovannucci et al. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women Cancer Epidemiol Biomarkers Prev 16 2007 2101 2109
223. R.Z. Stolzenberg-Solomon, P. Limburg, and M. Pollak et al. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers Cancer Epidemiol Biomarkers Prev 13 2004 438 444
224. B.M. Wolpin, D.S. Michaud, and E.L. Giovannucci et al. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts Br J Cancer 97 2007 98 104
225. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
226. U. Bergmann, H. Funatomi, and M. Yokoyama et al. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles Cancer Res 55 1995 2007 2011
227. E. Ohmura, M. Okada, and N. Onoda et al. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth Cancer Res 50 1990 103 107
228. O. Stoeltzing, W. Liu, and N. Reinmuth et al. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer Am J Pathol 163 2003 1001 1011
229. H. Zeng, K. Datta, and M. Neid et al. Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line Biochem Biophys Res Commun 302 2003 46 55
230. N.J. Zyromski, A. Mathur, and H.A. Pitt et al. Obesity potentiates the growth and dissemination of pancreatic cancer Surgery 146 2009 258 263
231. M.C. Chang, Y.T. Chang, and T.C. Su et al. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis Pancreas 35 2007 16 21
232. T. Krechler, M. Zeman, and M. Vecka et al. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus Neoplasma 58 2011 58 64
233. R. Huxley, A. Ansary-Moghaddam, and A. Berrington de Gonzalez et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies Br J Cancer 92 2005 2076 2083
234. H. Tang, X. Dong, and M. Hassan et al. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer Cancer Epidemiol Biomarkers Prev 20 2011 779 792
235. A. Krishnan, S.A. Nair, and M.R. Pillai Biology of PPAR gamma in cancer: a critical review on existing lacunae Curr Mol Med 7 2007 532 540